Northern Antibiotics has a pipeline of direct acting antibiotics derived from polymyxin B that aim to retain the antibiotic activity, but with a much broader therapeutic window. In preclinical ...

We are using DNA-encoded chemical libraries coupled with structure-based design to develop inhibitors for several clinically-relevant β-lactamases. Widespread resistance to β-lactams and other ...